Spravato is the first and only monotherapy to gain FDA approval for treatment-resistant depression.
Beyond the Ordinary Beyond the Obvious
Beyond the Ordinary Beyond the Obvious
Spravato is the first and only monotherapy to gain FDA approval for treatment-resistant depression.
